Financial Daily from THE HINDU group of publications
Friday, Feb 10, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Corporate - Overseas Borrowings


Panacea Biotec's $100-m FCCB

Our Bureau

NEW DELHI: Panacea Biotec has launched $100-million foreign currency convertible bonds to fund its expansion plans. The bonds will be issued for five years and can be converted into shares at a premium to the future price of the shares.

The bonds, which have a yield to maturity between 4.5 per cent and 7.25 per cent, will be listed on the Singapore stock exchange. Merrill Lynch International is the sole book runner to the offering.

Company officials were not willing to divulge details of the expansion plans. Its shares closed at Rs 270.40 (Rs 270.60) on the BSE.

More Stories on : Overseas Borrowings | Bio-tech & Genetics | New Projects

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
BHEL bags Rs 76-cr order for captive power plant


ONGC Bassein field starts production of oil — 9,000 barrels a day expected
23% Indo Rama interim
ADAG identifies deviations in gas pact, non-compete clause
Panacea Biotec's $100-m FCCB
Marico institutes `Innovation' awards
Kerala Minister to present Management award
Zee Gaurav awards presented
Award for Lanco Green
The way to build strengths through M&As
Trademark issue: Honda Motors sues TVS Motor
KPMG opens office in Pune
JK Industries plans investment recast
More than 30 M&A deals in January: Assocham
Fidelity takes stake in Suven
Godrej Sara Lee to set up new unit in Jammu
Motherboard manufacture — Gigabyte to make India hub for Asia-Pacific ops
Cipla gets marketing approval on generic Tamiflu
`Labour issue delaying decision on Toyota's small car plant' — Japanese trade team visits Bangalore
ONGC pact with Malaysian co
Kinetic, Taiwanese co tie up to manufacture scooters — New roll-out in nine months
Coal India seeks approval for IPO proposal — Plan to mop up Rs 3,000 cr



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line